Both in Pharmaceuticals
Obsidian Therapeutics vs Rigel Pharmaceuticals Inc. (New)
Over the past year OBX returned −18.9% and RIGL returned +7.0%; their daily moves had a correlation of 0.38.
OBX −18.9% RIGL +7.0%Growth of $1, one year, split-adjusted
| Metric | OBX | RIGL |
|---|---|---|
| Price | $14.43 | $50.53 |
| Market cap | $891.4M | $943.9M |
| Today | −2.43% | −1.52% |
| 1 month | +6.2% | +7.2% |
| 6 months | — | +71.1% |
| Year to date | — | +18.0% |
| 1 year | — | +59.8% |
| Revenue growth (YoY) | — | −22.6% |
| Gross margin | — | 89.2% |
| Net margin | — | 22.0% |
| P/E (TTM) | — | 2.9× |
| Price / sales | — | 3.4× |
| Net cash | — | $56.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 36.5% |
| Short % of float | 2.2% | 16.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).